Chlamydia pneumoniae infection in IL-10 knock out mice: Accelerated clearance but severe pulmonary inflammatory response

Microbial Pathogenesis

Volumn 45, Issue 1, 2008, Pages 25-29

  Penttilä, Tuula ^a,b   Haveri, Anu ^b   Tammiruusu, Anne ^b   Vuola, Jenni M ^b   Lahesmaa, Riitta ^c,d   Puolakkainen, Mirja ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

Chlamydia pneumoniae; Cytokines; Inflammation; Mouse model

Indexed keywords

INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; LUNG PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; WILD TYPE;

ANIMALS; CELL PROLIFERATION; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERLEUKIN-10; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PNEUMONIA, BACTERIAL;

CHLAMYDOPHILA PNEUMONIAE; MUS;

EID: 44649097560     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2008.02.004     Document Type: Article

References (12)

1. Campbell L.A., Blessing E., Rosenfeld M., Lin T., and Kuo C. Mouse models of C. pneumoniae infection and atherosclerosis. J Infect Dis 181 Suppl. 3 (2000) S508-S513
2. Huang J., DeGraves F.J., Lenz S.D., Gao D., Feng P., Li D., et al. The quantity of nitric oxide released by macrophages regulates Chlamydia-induced disease. Proc Natl Acad Sci U S A 99 (2002) 3914-3919
3. Vuola J., Puurula V., Anttila M., Mäkelä P.H., and Rautonen N. Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge. Infect Immun 68 (2000) 960-964
4. de Kruif M.D., van Gorp E.C.M., Keller T.T., Ossewaarde J.M., and ten Cate H. Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research. Cardiovasc Re 65 (2005) 317-327
5. Yang X., HayGlass K.T., and Brunham R.C. Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of C. trachomatis mouse pneumonitis infection. J Immunol 156 (1996) 4338-4344
6. Yang X., Gartner J., Zhu L., Wang S., and Brunham R.C. IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J Immunol 162 (1999) 1010-1017
7. Rottenberg M.E., Rothfuchs A.C.G., Gigliotti D., Svanholm C., Bandholz L., and Wigzell H. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J Immunol 162 (1999) 2829-2836
8. Caspar-Bauguil S., Puissant B., Nazzal D., Lefevre J.C., Thomsen M., Salvayre R., et al. Chlamydia pneumoniae induces interleukin-10 production that downregulates major histocompatibility complex class I expression. J Infect Dis 182 (2000) 1394-1401
9. Igietseme J.U., Ananaba G.A., Bolier J., Bowers S., Moore T., Belay T., et al. Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development. J Immunol 164 (2000) 4212-4219
10. Beatty W.L., Byrne G.I., and Morrison R.P. Morphologic and antigenic characterization of interferon- γ-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci U S A 90 (1993) 3998-4002
11. Kuhn R., Lohler J., Rennick D., Rajewsky K., and Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
12. Kyläniemi M, Haveri A, Vuola J, Puolakkainen M, Lahesmaa R. Gene expression signatures characterizing the development of lympohocyte response during experimental Chlamydia pneumoniae infection, manuscript in preparation.